Dive Brief:

The Trump administration will pilot a voluntary program next year in which pharmaceutical companies can offer rebates for certain drugs to hospitals participating in the 340B drug discount program.

The pilot is a significant departure from the traditional 340B model, which gives hospitals upfront discounts for certain medications. Under the pilot, hospitals would receive rebates coordinated by drug manufacturers, according to the Health Resources and Services Administration . To receive reimbursement, providers will submit data to manufacturers within 45 calendar days of dispensing the drug, allowing for some extenuating circumstances, and then receive a rebate within 10 days.

The American Hospital Association immediately criticized the program on Thursday, warning d

See Full Page